Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment
Figure 11
Zone of inhibition of CIPSTE formula (4) compared to SLNs (1), control (2), and physical mixture samples (3) after 6 (a) and 24 (b) hours for P. aeruginosa and S. aureus bacterial strains.
